Culture, Acid-Fast Bacilli, Bronchoalveolar Lavage
Tuberculosis caused by Mycobacterium tuberculosis (MTB) has been a challenging infection for many decades. In 2012, the incidence of MTB infection was as high as 8.6 million worldwide, affecting both developing and industrialized nations. MTB is second only to human immunodeficiency virus (HIV) as the most lethal infectious agent, with 1.3 million people dying of tuberculosis in 2012. In the US, the incidence of MTB infection is 3.2 persons/100,000 population, with HIV infection and immunosuppression being important predisposing factors. HIV infection also predisposes to infection by Mycobacterium avium complex (MAC), which is somewhat clinically similar to MTB infection. The true incidence of MAC infection is hard to estimate at least in part due to difficulty in the clinical diagnosis of this infection.
Mycobacterial species are broadly classified into two categories —Mycobacterium tuberculosis complex and nontuberculous mycobacteria (atypical mycobacteria). Mycobacterium tuberculosis complex consists of M. tuberculosis (MTB) and closely related species; the clinically important species includes M. bovis, M. bovis BCG, M. africanum, M. microti and M. pinnipedii. The atypical mycobacteria are subclassified based on their growth characteristics and pigment production (in vitro). MAC is a slow grower and does not produce any pigment while M. kansasii grows slowly and produces yellow pigment on the agar plates upon exposure to light (photochromogen).
Laboratory identification of mycobacterial species involves isolation from the clinical specimens (through decontamination and purification), extended incubation to include slow growers, growth and pigmentation on agar plates, bacterial morphology (acid-fast stain/Rhodamine-Auramine stain), biochemical characteristics and molecular typing (nucleic acid hybridization, PCR and sequencing).
Clinical presentation of mycobacteria infections is non-specific and poses a diagnostic challenge to the clinician. The presenting symptoms include chronic non-productive cough, low-grade fever, unexplained weight loss, and failure to thrive (in children). Most mycobacterial infections are acquired through the respiratory route and cause chronic lung disease, including bronchitis, granulomatous abscess, lung nodules (mimicking malignancy), cavitary lung lesions and mediastinal lymphadenopathy.
There are several methods used to detect and identify acid-fast bacilli today. Culture is still a gold standard; however, limitations on viability of the specimen, inability to detect from fixed tissues and long turnaround time makes culture less attractive than available molecular methods.
- Diagnosis of pulmonary tuberculosis caused by M. tuberculosis
- Differential diagnosis of tuberculosis caused by Mycobacterium avium complex or other Mycobacteria
- As an aid in diagnosis of atypical pneumonia caused by non-tuberculosis species (MAC, M. intracellulare)
- As an aid in diagnosis of granuloma in immunocompromised patients caused by non-tuberculosis species (MAC, M. intracellulare)
- Isolation of M. tuberculosis from specimens implies infection by M. tuberculosis and diagnosis of tuberculosis
- Isolation of other mycobacteria from specimens implies infection by other mycobacterial species related to non-tuberculosis state
No growth (Mycobacteria not isolated)
Bronchoalveolar lavage (BAL), pleural fluid, sputum, blood, bone marrow, Cerebrospinal fluid, lung tissue, other fresh tissues.
Bronchial wash and sputum must be collected in sterile container.
Note: Three sputum specimens should be collected at 8-24 hour intervals (24 hours when possible) and should include at least one first morning specimen.
The specimen should be refrigerated if not processed immediately.
Stability
- Ambient: 24 hours
- Refrigerated: 3-5 days
1-4 weeks.
- Infect Dis Clin North Am. 2015 Sep;29(3):477-502. [PMID: 26188605]
- Expert Rev Anti Infect Ther. 2011 Apr;9(4):457-69. [PMID: 21504402]
- Lancet. 2003 Sep 13;362(9387):887-99. [PMID: 13678977]
- Nat Rev Immunol. 2012 Jul 13;12(8):581-91. [PMID: 22790178]
- Clin Infect Dis. 2011 Jun;52(11):1350-5. [PMID: 21596676]
- PLoS One. 2011;6(9):e24789. [PMID: 21961045]
- Curr Microbiol. 2012 Nov;65(5):493-9. [PMID: 22797866]
- Arch Pathol Lab Med. 2003 May;127(5):554-60. [PMID: 12708897]
- Tuber Lung Dis. 2000;80(3):131-40. [PMID: 10970761]
- Am J Respir Crit Care Med, 2005;172:1169-1227. [PMID: 16249321]
- J Clin Microbiol. 2002 Sep;40(9):3482-4. [PMID: 12202598]
- Center for Disease Control, data and statistics on tuberculosis http://www.cdc.gov/TB/statistics/ accessed 10.31.2013 World Health Organization, factsheets on tuberculosis http://www.who.int/mediacentre/factsheets/fs104/en/ accessed 10.31.2013